Advertisement
Home Tags Drug Approvals

Tag: Drug Approvals

The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults.

FDA Approves Siliq for Plaque Psoriasis

0
Injected medication approved for use by patients who've failed other treatments
Emflaza (deflazacort) has been approved by the U.S. Food and Drug Administration to treat Duchenne muscular dystrophy in patients 5 years and older

FDA Approves Emflaza for Duchenne Muscular Dystrophy

0
Approved to treat Duchenne muscular dystrophy in patients 5 years and older
A set of screening tests designed to detect four rare metabolic disorders in newborns has been approved by the U.S. Food and Drug Administration.

FDA Approves Newborn Screening Tests for Metabolic Disorders

0
Screens used to detect Mucopolysaccharidosis Type 1, Pompe, Gaucher, and Fabry
Trulance has been approved by the U.S. Food and Drug Administration to treat persistent idiopathic constipation in adults.

FDA Approves Trulance for Chronic Idiopathic Constipation

0
Drug designed to stimulate secretion of intestinal fluid
The drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.

FDA Grants Fast-Track Approval to Ovarian Cancer Drug

0
Rubraca's use is specific to women with deleterious BRCA mutations
Maci (autologous cultured chondrocytes on porcine collagen membrane) has been approved by the U.S. Food and Drug Administration to repair symptomatic

FDA OKs Autologous Cellularized Scaffold for Knee Cartilage Repair

0
For symptomatic, full-thickness cartilage defects of the knee in adult patients
Intrarosa (prasterone) has been approved by the U.S. Food and Drug Administration to treat women who have moderate-to-severe pain during sexual intercourse caused by postmenopausal vulvar and vaginal atrophy.

FDA Approves Intrarosa for Postmenopausal Pain During Sex

0
Drug contained in a once-daily vaginal insert
The Amplatzer PFO Occluder device has been approved by the U.S. Food and Drug Administration to prevent another stroke among patients who have had at least one prior stroke involving a patent foramen ovale.

FDA Approves Device to Prevent Recurrent Strokes in PFO Patients

0
For patients who had prior stroke related to patent foramen ovale
Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft tissue sarcomas.

FDA Approves New Treatment for Advanced Soft Tissue Sarcoma

0
Sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery
The first automated insulin delivery device for type 1 diabetes has been approved by the U.S. Food and Drug Administration for patients aged 14 and older.

FDA Approves ‘Artificial Pancreas’ for Type 1 Diabetes

0
MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin